- Country: Finland
- Summary: Controls: Mycobacterium Tuberculosis, Streptococcus Agalactiae, Clostridioides Difficile, Mrsa, Vre and Carbapenemase Genes Molecular Controls
- FIT Ref No: 119567386
- Deadline: 04 Jun 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: HUS 527-2024 / Inquiry
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- With this request for information, the HUS Group wants to map the market supply of the molecular controls used in the quality assurance of the bacteriology laboratory and the HUS area of maternity wards regarding the areas specified below. Controls should be suitable for Genexpertfor the hardheid (cepheid) and clostridioides difficile controls for BD MAX (Becon Dickinson). Sub -areas: 1) Genexpert MTB Ultra test (cepheid), three different controls: - Mycobacterium tuberculosis positive, rifampicini (rif) negative- mycobacterium tuberculosis positive,Rifampicin Positive - Mycobacterium tuberculosis negativem.tuburculosis identification and antibiotic sensitivity results should include the same control sample2) Genexpert MTB/XDR test (CEPHEID), three different controls: - Mycobacterium tuberculosis post.Fluoroquinolone (flq) posit., amikasin (college) posit., Canamycin (kan) posit., caperomycin (cap) posit., Etionamide (ETH) posit. - Mycobacterium tuberculosis posit., Isoniazide (inh) negat., Flurooconolone (flq) negat., Amikasine (Bachelor of Arts), Canamycin (Kan) Negat., Capreomycin (CAP) Negat.,Etionamide (ETH) negat.- Mycobacterium tuberculosis negative. M.Tuberculosis identification and antibiotic sensitivity results should be included in the same control sample3) Genexpert Xpress Xpress GBS test (CEPHEID):- Streptococcus agalactiae positive control- Streptococcus agalactiaeneg...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINControls: Mycobacterium Tuberculosis, Streptococcus Agalactiae, Clostridioides Difficile, Mrsa, Vre and Carbapenemase Genes Molecular Controls - Finland Tender
The HUS, a Government sector organization in Finland, has announced a new tender for Controls: Mycobacterium Tuberculosis, Streptococcus Agalactiae, Clostridioides Difficile, Mrsa, Vre and Carbapenemase Genes Molecular Controls. This tender is published on FinlandTenders under FIT Ref No: 119567386 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-06-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
